L’organisation d’une salle de réunion peut être un défi, mais ce n’est pas une fatalité. Avec un aménagement, un mobilier et une technologie adaptés, vous pouvez créer un espace efficace pour des réunions productives. Dans cet article de blog, nous allons explorer comment concevoir une salle de réunion efficace qui permet aux participants de collaborer de manière transparente et productive. Nous aborderons des sujets tels que la création de la bonne atmosphère, le choix de la bonne disposition des sièges, la sélection de la bonne technologie et d’autres conseils qui peuvent vous aider à créer un environnement propice à la collaboration. Si vous cherchez des moyens de rendre votre salle de réunion plus efficace et plus productive, poursuivez votre lecture !
1. Pourquoi la conception d’une salle de réunion efficace est importante
Organiser une salle de réunion peut être un défi, mais c’est l’un des aspects les plus importants pour assurer la productivité et encourager la collaboration au sein d’une entreprise. La conception d’une salle de réunion doit être adaptée à l’objectif de la réunion et à la taille du groupe. Il est important de prêter attention à chaque détail, car cela peut avoir un impact significatif sur le climat et le résultat de la réunion. Une bonne conception de salle de réunion peut aider à créer un environnement favorable pour une collaboration efficace et productive.
2. Conseils pour créer la bonne atmosphère dans votre salle de réunion
L’atmosphère joue un rôle crucial dans la productivité et la collaboration lors des réunions. Vous devrez donc vous assurer que ll’atmosphère est propice à des réunions productives. Pour créer la bonne atmosphère, vous devrez prendre en compte plusieurs éléments :
– Le mobilier approprié. Assurez-vous que les sièges sont confortables et que la disposition est ergonomique et facilite les interactions.
– L’utilisation de matériel audio-visuel. Utilisez des écrans interactifs, des tableaux blancs numériques ou d’autres outils pour permettre aux participants de partager leurs pensées et idées.
– La lumière, le son et la température de la pièce doivent être adaptés pour créer une atmosphère agréable et productive.
Lorsqu’il s’agit d’organiser des réunions produitves, la conception et l’aménagement de votre salle de réunion sont aussi importants que le choix des participants et les sujets abordés. Il est essentiel de concevoir une pièce qui inspire confiance, productivité et collaboration.
Comment choisir une disposition appropriée des sièges qui permette aux participants de collaborer facilement
Lorsque vous organisez une réunion, il est important de penser à la façon dont vous disposez les sièges. Vous pouvez choisir des chaises confortables et disposées de manière à ce que les gens puissent facilement parler et travailler ensemble. Veillez à ce que chacun puisse se voir et entendre ce qui se passe. Il est également important de s’assurer que la disposition des sièges offre à chacun suffisamment d’espace personnel.
Si vous organisez une réunion à plusieurs, choisissez une table assez grande pour accueillir tous les participants et prévoyez assez d’espace pour s’étendre. Vous pouvez opter pour des chaises autour de la table si cela fonctionne mieux, ou disposer les sièges en cercle afin que personne ne soit plus proche qu’un autre. Si vous avez des présentations ou des travaux en groupe, vous pouvez penser à disposer les sièges de manière à ce qu’il y ait suffisamment d’espace pour écrire et fonctionner librement.
Huntington’s Disease (HD) is a rare, neurodegenerative disorder that affects the brain and results in physical, mental and behavioral symptoms. It is caused by a genetic mutation and can lead to intellectual decline, impaired movement and changes in personality. Though the exact cause of Huntington’s Disease remains unknown, there are treatments available to help manage symptoms.
Symptoms of Huntington’s Disease
Common symptoms of Huntington’s Disease include difficulty walking or balancing, involuntary movements, emotional instability that can manifest as depression or irritability, and problems with thinking, planning and problem-solving. Other physical manifestations of the disorder may include unsteadiness, stiffness or jerky, uncontrolled movements. In addition to these physical symptoms, people living with HD often experience cognitive decline, including difficulty in forming new memories and difficulties paying attention.
Causes of Huntington’s Disease
Huntington’s Disease is caused by a mutated gene responsible for creating a protein called huntingtin. This mutated gene, inherited from either parent, causes the body to produce an unusually large amount of the protein, which can then damage parts of the brain responsible for controlling thought, emotions and movement. Researchers are still working on understanding exactly how this mutation affects the brain cells.
Diagnosis for Huntington’s Disease
Diagnosis of Huntington’s Disease is based on an individual’s family history, a physical exam, and a neurological exam. There are also genetic tests and imaging scans available to help confirm or rule out the condition. Genetic counseling and other forms of psychological therapy can be beneficial for those living with implications due to their diagnosis. Treatments for Huntington’s Disease Treatments for Huntington’s Disease are aimed at symptom management, typically focusing on medications to improve movement and speech, psychotherapy to help manage the emotional effects, and occupational therapy to help with day-to-day activities. Surgery is only sometimes considered if symptoms become severe enough. Additionally, gene editing has been explored as a potential therapy in some cases.
Prevention of Huntington’s Disease
Huntington’s Disease is an inherited condition, so there is no way to prevent it. Genetic counseling and testing may be useful for individuals at risk of passing it on to their children. Additionally, taking steps to maintain a healthy diet and lifestyle can help manage the symptoms but will not prevent the onset of any neurological disorder.
Tips for Coping
Huntington’s disease is a progressive neurological condition with a wide range of symptoms that can be difficult to manage. To help cope, it is important to keep things simple by making sure to get enough rest, exercise, and nutrition. One practical suggestion for those dealing with HD is to carry earplugs to help block out noise that may otherwise be uncomfortable. It is also very helpful to carry calendars and sticky notes when you are out and about, as well as setting up a message center in your home for other family members to check. Additionally, using voicemail and recording systems can help make sure you don’t miss any messages or phone calls, while using recipes with a numbering system can help follow directions more easily.
Mental disorders refer to a broad range of conditions that can affect a person’s thinking, feeling, mood and behavior. These conditions include depression, anxiety disorders, bipolar disorder, schizophrenia and obsessive-compulsive disorder (OCD).
The dates for the classification of these mental health conditions are listed here.
Philippe Pinel (1745-1826), French psychiatrist, is interested in the mental pathology of the elderly and its disabling aspect. We must give him the first classification of mental illness. He identifies different categories of patients.
Jean-Etienne Esquirol (1772-1840), French psychiatrist, deepens the work of Pinel: he establishes the different forms of melancholy, establishes the distinction between hallucinations and illusions and draws a parallel between madness and passions.
Joseph Daquin (1732-1815), French psychiatrist, classifies the insane into different groups: the insane, the quiet insane, the extravagant, the insane and the insane in dementia.
1810 : there are differences on the notion of mental illness; three schools stand out: the French, Scottish and English schools.
Antoine Ritti (1844-1920), sends a report (1895) on the psychoses of the elderly subject.
Jules Seglas (1856-1939), French psychiatrist, particularly studied the classification of disorders and diseases (called nosography) of psychoses including delusions and hallucinations.
Karl Ludwig Kahlbaum (1828-1899), German psychiatrist, considers mental illness to be an illness that develops over time.
1860 : demonstration of the existence of a correlation between mental functions and the different parts of the brain. For example, Arnold Pick (1851-1924; Czech Republic) shows that the dysfunction of language and praxis is associated with damage to the temporal and frontal lobes.
1887 : S. Beljahow reports that neurons in the cerebral cortex of elderly patients with dementia are distorted and in the form of debris:
Emil Kraepelin (1856-1926), German psychiatrist, distinguished in 1889 manic-depressive psychoses from early dementias. He defines psychotic states as a profound alteration in the subject’s consciousness. He will publish eight editions of his Treatise on Psychiatry from 1883 to 1909.
Emil Redlich (1866-1930), Austrian neurologist, described, in 1898, plaques in the cerebral cortex of a 78-year-old woman who suffered from senile dementia. He is probably the first to speak of ‘senile plaques’.
Andre Leri (1875-1930), French neurologist, presented a report in 1906 in which he described histological lesions (these lesions are amyloid plaques) that Alois Alzheimer would later describe as characteristic of Alzheimer’s disease.
Alois Alzheimer (1864 – 1915), German psychiatrist, followed the case of a 51-year-old patient suffering from dementia with cognitive alterations, delirium and hallucinations, until her death in 1906. By examining the brain, he discovered histological lesions (called plaques and neurofibrillary degeneration) characteristic of Alzheimer’s disease. Alois Alzheimer published a second identical case in 1911 in a younger person.
1906 : Solomon C. Fuller (1872-1953), American psychiatrist, describes the presence of neurofibrillary degeneration in senile dementia.
Emil Kraepelin (1856-1926), subsequently proposed designating this type of dementia by the name of his colleague Alois Alzheimer.
1912: E. Kraepelin defines « Alzheimer’s disease » as a rare pre-senile dementia affecting the young subject, and qualified as « senile dementia » the vascular dementias of the elderly subject, caused by a lack of oxygen (caused by a blockage of vessels) in the brain. The idea of the vascular origin of senile dementia lasted until the 1960s, with the common use of terms such as arteriopathic dementia or cerebral vascular insufficiency .
Around 1900 , two forms of senile dementia were identified: dementia linked to arteriosclerosis (aging of the arteries and arterioles which harden) and subcortical dementia which affects the cerebral structures located under the cortex.
At the beginning of the 20th century , elderly people with cognitive and/or behavioral disorders were very often placed in institutions against their will until their death. Around 1930, Grégoire Halberstadt devoted himself to the clinical study of early dementia.
1949 : publication of the 6th revision (ICD-6) of the International Statistical Classification of Diseases, containing for the first time a classification of mental disorders. The International Classification of Diseases is published by the World Health Organization (WHO)
1952 : The American Psychiatric Association publishes the first Diagnostic and Statistical Manual of Mental Disorders (DSM) which aims to create a common reference of mental disorders. In all, five editions will be published: the DSM I (1952), DSM II (1968), DSM-III (1980) and its revised form DSM-III-R (1987), the DSM-IV (1994) and its revised DSM-IV-TR (2000). A sixth edition (DSM V) is planned for 2013.
Mental disorders include five axes
Axis I : Major clinical disorders: depression, anxiety disorders, bipolar disorder, attention disorder with or without hyperactivity, autism spectrum disorders, anorexia nervosa, bulimia and schizophrenia.
Axis III : Specific medical aspects and physical disorders: these are brain damage and other medical/physical disorders that can aggravate existing illnesses or symptoms.
Axis IV : Psychosocial and environmental factors
Axis V : Global Assessment of Functioning Scale
Around 1960 : reorganization of psychiatry as a whole; importance of the social aspect of patient care; global approach to the patient which takes into account the psychological and social aspects.
1969 : first geriatric psychiatry manual published by the Swiss psychiatrist Christian Müller.
1970s : Doctors realized that the majority of senile dementias had the characteristics of Alzheimer’s disease.
1974 : Hachinski described dementia by multiple infarctions, dementia distinct from that of the Alzheimer type, and established a scale which bears his name (scale adapted by Loeb and Gandolfo, in 1983, after the support of the scanner).
Beginning of the 1980s : the care of the elderly is the subject of particular attention from French psychiatry. In 1981, a summary of psychogeriatrics was published in French by the Swiss psychiatrists C. Müller and Jean Wertheimer.
1981 : introduction of the term psychogeriatrics, defined as the medical discipline concerned with the prevention of the consequences of aging, the psychology of nursing practice, the relational and behavioral problems of the patient’s family (caregiver) and professional environment. Not to be confused with psychogerontology, which is the science that seeks to understand, and possibly correct, the behavior of the aging person.
1990 : tenth revision of the International Statistical Classification of Diseases (ICD-10) with its chapter 5 on ‘mental and behavioral disorders’. This chapter is structured as follows:
1. Organic mental disorders, including symptomatic disorders. – Dementia in Alzheimer’s disease (early onset, late onset, atypical or mixed form, unspecified). – Vascular dementia (with acute onset, multiple infarcts, mixed, cortical and subcortical, unspecified). – Dementia associated with other diseases classified elsewhere (Pick’s disease, Creutzfeldt-Jakob disease, Huntington’s disease, Parkinson’s disease, human immunodeficiency virus (HIV), other diseases). – Organic amnesic syndrome, not induced by alcohol or other psychoactive substances. – Delirium, not induced by alcohol or other psychoactive substances (not added to dementia, added to dementia, unspecified). – Other mental disorders, due to brain damage or dysfunction, or to a physical condition (examples: organic hallucinatory state, organic catatonia, organic delusional disorder, mood disorders, organic anxiety disorder, dissociative disorder, lability (asthenia) emotional, mild cognitive impairment). – Personality and behavioral disorders due to brain disease, injury and dysfunction (eg post-encephalitic syndrome, post-concussion syndrome). – Organic or symptomatic mental disorder, unspecified.
2. Mental and behavioral disorders related to the use of psychoactive substances .
3. Schizophrenia, schizotypal disorders and delusional disorders .
5. Neurotic Disorders, Disorders Related to Stressors and Somatoform Disorders . – Phobic anxiety disorders (eg agoraphobia, social phobias). – Other anxiety disorders (examples: panic disorder, generalized anxiety). – Obsessive Compulsive Disorder. – Reactions to a major stressor, and adjustment disorders. – Dissociative disorders. – Somatoform disorders. – Other neurotic disorders (eg neurasthenia).
6. Behavioral syndromes associated with physiological disturbances and physical factors .
7. Personality and behavioral disorders in adults .
8. Mental retardation .
9. Disorders of psychological development .
10. Behavioral and emotional disorders usually appearing during childhood and adolescence .
11. Mental disorder, not otherwise specified .
1994 : Hachinski advanced the concept of “vascular cognitive disorders” encompassing vascular dementia. According to him, vascular dementia is not strictly speaking a dementia syndrome as it is defined for Alzheimer’s disease.
1999 : publication of the book ‘Psychiatry of the elderly subject’ (authors Jean-Marie Léger, Jean-Pierre Clément, Jean Wertheimer).
2003 : O’Brien et al. propose the term vascular cognitive impairment, which encompasses the different forms of vascular damage. These disorders are not necessarily accompanied by dementia.
2004 : Roman et al. propose the term “vascular cognitive diseases”. This term encompasses the notions of vascular cognitive deficit and vascular dementia. Vascular cognitive deficit refers to the concept of « mild cognitive decline » (a stage often preceding Alzheimer’s disease), and is therefore limited to non-demented patients.
Hallucinations are signs of mental illness, but they don’t always mean that a person is sick. They are, in fact, quite common.
A 2015 study done in Europe found that 7.3% of people said they had heard voices all their life. A study from South Africa on hallucinations in the general population estimated the higher rate at 12.7%
Scientists don’t fully understand why some people have hallucinations and others don’t. They don’t know what causes them in people with mental disorders such as schizophrenia.
Types of Hallucinations
Hallucinations are not always a sign of a mental health disorder. They can occur whenever there is a change in brain activity.
Some people are more vulnerable to hallucinations when they fall asleep or partially wake up.
A 2019 study in mice that took a hallucinogenic drug found that the animals had less activity in brain regions that researchers have associated with processing incoming visual information.
This observation suggests that a hallucination could be the brain’s way of compensating for a drop in sensory information.
There are many types of hallucinations, including:
Auditory : a person hears something that is not there, such as a voice or a radio.
Visual : they cause someone to see something that is not real, such as a person or an animal.
Olfactory : they can occur when a person smells something that is not there.
Gustatory : they transmit the taste to someone of something that he has not eaten.
Tactile : they occur when a person has the impression that something or someone has touched them.
Somatic : These hallucinations can affect the whole body, causing unreal sensations like that of insects crawling on the skin.
The causes
Many medical conditions and other factors can cause hallucinations.
Drugs
Medicines called hallucinogens can cause hallucinations. These drugs temporarily change the way the brain processes and sends information, causing unusual experiences and thoughts.
LSD, dimethyltryptamine (DMT) and certain mushrooms are common hallucinogens.
Schizophrenia
Schizophrenia is a mental illness that changes the way a person thinks and behaves. It can also cause psychosis, which is a loss of contact with reality.
People with psychosis may experience delusions and hallucinations and exhibit behaviors that are not typical.
Antipsychotic medications can help manage symptoms, and some people do better with treatment.
Postpartum Mental Health Disorders
Many new parents struggle with postpartum depression and anxiety.
Some suffer from postpartum psychosis, but this is less common. For example, a mother thinks she hears her baby cry when the baby does not.
Since postpartum psychosis can put the baby at risk and disrupt the parent-child relationship, prompt treatment is essential. Therapy, medication, and social support can help.
Anxiety and depression
People with anxiety and depression may experience periodic hallucinations. They are usually very brief and often relate to the specific emotions felt by the person. For example, a depressed person may hallucinate that someone tells them that they are worthless.
Treatment of the underlying disorder can often eliminate these hallucinations.
Alcohol withdrawal
Alcohol withdrawal can cause hallucinations, especially in people who have a severe withdrawal syndrome called delirium tremens.
A person with delirium tremens may also become very sick, vomit, or shake. Symptoms often disappear after several days.
Dementia and other brain disorders
Dementia progressively damages the brain, including areas involved in sensory processing. People with mid-to-late stage dementia may experience auditory and visual hallucinations.
Occasionally they see dead people. In other cases, their hallucinations can be terrifying and can trigger feelings of paranoia and panic that prevent them from trusting caregivers.
Medications can help relieve these symptoms.
Epilepsy
Sometimes hallucinations are a symptom of a seizure disorder. A person may experience hallucinations during or after a seizure which can be avoided by treating the seizures in most cases.
Migraines
Some people with migraines have hallucinations during or just before a migraine. These hallucinations are frequently visual. A person may see spots and colors that are not there, or other unusual images.
Sleeping troubles
Some people have hallucinations that doctors associate with sleep disturbances. Hallucinations usually appear when a person falls asleep or wakes up.
In some cases, the hallucination occurs with an episode of sleep paralysis, which occurs when a person wakes up and is temporarily unable to move.
Treating sleep disorders can help relieve symptoms. In some cases, knowing that the hallucinations occur because of brain changes during the sleep cycle can make them less scary.
Sensory disorders
People who are hard of hearing or visually impaired can experience hallucinations. This may be due to brain changes in the regions responsible for processing sensory, visual or auditory information.
Other causes
In some cases, hallucinations may not be related to disease or medication. For example, in some religious traditions, a person may report an auditory hallucination. A person sleeping in a house they believe is haunted may hear noises or see ghostly figures due to increased anxiety.
Hallucinations are not delusions
A hallucination is not a delusion, although the two are closely related. A delusion is a false belief, while a hallucination is a false perception.
Many people may have fallen in love with optical illusions and other mental tricks. However, a hallucination is more than an error of perception.
People with hallucinations see or hear things that aren’t actually there and don’t match the experiences of others around them.
They may also believe in the reality of their hallucinations or attach specific meaning and false beliefs to them. These attached false beliefs are illusions.
Other symptoms associated with hallucinations
Hallucinations often signal an underlying problem with how the brain processes information, such as when someone with dementia develops hallucinations or depression triggers psychosis.
Some other symptoms accompanying hallucinations include:
Fibromyalgia is a disorder that causes chronic pain, fatigue and other symptoms throughout the body. It’s estimated to affect up to 10 million Americans, but many don’t realize they have it because its symptoms can be mistaken for other conditions. This article explores its types, diagnosis, treatments and more.
What is Fibromyalgia?
Fibromyalgia is a chronic condition characterized by widespread pain and fatigue. It is often associated with mood disorders, such as depression and anxiety, sleep disturbances and digestive problems.
Symptoms may vary in intensity throughout the day but are generally aggravated by physical activity or stress. Diagnosis typically involves an extensive medical examination as well as ruling out other medical conditions that have similar symptoms.
Types of Fibromyalgia
This condition can be classified into three categories: localized, systemic, and mixed. Localized fibromyalgia typically affects a specific area such as the neck or back. Systemic fibromyalgia involves pain throughout the body. Mixed forms of the disorder occur when both localized and systemic symptoms are present.
Additionally, some individuals may experience more severity in certain areas than others, leading to regional differences in pain levels.
Common Symptoms
Fibromyalgia is often associated with pain, but this disorder is associated with several other symptoms as well.
These common symptoms include chronic fatigue, difficulty sleeping, cognitive impairment, headaches and nausea, depression and anxiety, painful trigger points on the body, joint stiffness, tingling or numbness in hands or feet, abdominal pain and tenderness around the neck and shoulders.
Treatment Options
While there is no cure for this condition, there are many treatments that can help to manage the condition. Talk therapy, physical therapy, and medication are common options for treating the disorder. Many patients find relief with a combination of lifestyle changes such as stress management and exercise, relaxation techniques, and dietary modifications.
Medications used to treat fibromyalgia include painkillers, antidepressants, anticonvulsants to reduce nerve-related pain, muscle relaxants and topical creams for tender points.
Managing the Symptoms of Fibromyalgia
A balanced approach to symptom management is the best way to deal with fibromyalgia. This includes proper sleep habits, regular physical activity, relaxation techniques, and dietary modification.
Pain medications such as non-steroidal anti-inflammatory drugs may help control pain and stiffness.
Muscle relaxants, antidepressants, and anticonvulsants can also be helpful in relieving symptoms. In some cases, specific therapies like acupuncture or chiropractic treatments can provide relief from mild muscle spasms or joint stiffness caused by fibromyalgia.
La thérapie par la danse et le mouvement est une forme de psychothérapie qui utilise la danse et le mouvement pour améliorer la santé mentale et physique. Il est fondé sur l’idée que l’esprit et le corps sont interdépendants, donc quand l’un est affecté, l’autre le sera aussi.
Grâce à cette thérapie, les personnes peuvent améliorer leur bien-être en développant leur force, leur coordination, leur équilibre, leur flexibilité, leur expression personnelle et leurs aptitudes sociales.
Afin d’améliorer son bien-être général, la thérapie par la danse et le mouvement peut être une forme expressive de thérapie qui encourage la santé physique et mentale.
Les gens peuvent utiliser des mouvements de danse pour exprimer leurs sentiments et leurs émotions afin de faciliter l’expression de soi, la créativité et la connexion avec leur moi intérieur grâce à des séances avec un professionnel qualifié.
Comment ça marche?
Il semble que la danse-thérapie favorise la santé en unifiant et en coordonnant tous les aspects d’une personne, tels que :
En danse, la communication non verbale est aussi importante que la communication verbale.
En plus de servir de moyen de communication, le mouvement peut également être expressif, fonctionnel ou développemental.
L’évaluation et l’intervention peuvent toutes deux être accomplies par le mouvement.
Effets bénéfiques possibles de la thérapie par la danse et le mouvement
Les recherches sur les bienfaits physiques, mentaux et émotionnels de la danse-thérapie ne sont pas concluantes. Bien que d’autres études soient nécessaires, certaines preuves suggèrent que cela pourrait être bénéfique dans les domaines suivants :
Santé mentale
Les résultats d’une méta-analyse de 2019 portant sur 41 essais cliniques et impliquant 2 374 participants ont indiqué que la danse-thérapie améliore :
Il est également possible que ces avantages soient à long terme, notamment l’anxiété, la dépression, la qualité de vie et les capacités cognitives.
Une dépression
Contrairement à la méta-analyse ci-dessus, une revue de 2019 a évalué huit essais cliniques qui ont examiné les effets de la thérapie par la danse et le mouvement sur 351 adultes aux prises avec la dépression.
Les auteurs ont qualifié les preuves de qualité modérée à élevée et ont conclu que l’intervention pourrait offrir un traitement efficace pour les adultes souffrant de dépression. Comme la plupart des études incluses excluaient les enfants, les adolescents et les personnes âgées, elles n’ont pas pu évaluer son efficacité pour ces populations.
Prévenir les chutes
En améliorant la démarche, l’équilibre et la force musculaire, les auteurs d’une revue de 2017 ont examiné si la danse, une activité populaire chez les personnes âgées, peut aider à prévenir les chutes. Les chutes étant l’une des principales causes de maladie et de décès, les auteurs ont passé en revue 10 essais cliniques qui ont exploré la possibilité que la danse prévienne les chutes. Le nombre total de participants était de 680.
Les auteurs notent que la danse semble être sans danger et démontre des avantages pour le bien-être des personnes âgées, malgré la nature préliminaire de leurs résultats et le manque de données à long terme.
la maladie de Parkinson
Une revue de 2018 a examiné 40 études et cinq revues portant sur les effets de la danse et de la musique sur les symptômes de la maladie de Parkinson, qui altère la démarche, ce qui peut augmenter le risque de chutes. Les résultats ont indiqué que les interventions pourraient améliorer la marche.
Soins aux patients atteints de cancer
En plus d’affecter la santé physique, le cancer affecte souvent les émotions et la socialisation. Afin de résoudre ces problèmes, les soins actuels contre le cancer incluent de plus en plus des interventions psychosociales. Une étude de 2015 a examiné trois essais cliniques impliquant 207 personnes atteintes d’un cancer du sein afin d’examiner les avantages de la thérapie par la danse et le mouvement contre le cancer.
Dans l’analyse des données, des résultats mitigés ont été trouvés, mais l’intervention pourrait aider en :
Cependant, il n’a trouvé aucune preuve que la danse-thérapie puisse réduire la somatisation, qui est la présentation de multiples symptômes physiques causés par des facteurs psychologiques.
Une revue de 2021 a révélé que la danse-thérapie pouvait améliorer la qualité de vie des personnes atteintes d’un cancer du sein, mais a noté que cette thérapie pourrait être plus efficace lorsqu’elle est associée à d’autres thérapies.
Pression artérielle
En 2020, une méta-analyse de cinq essais cliniques a examiné les effets de la danse-thérapie sur la tension artérielle. Malgré le petit nombre d’essais, les résultats ont indiqué que l’intervention pouvait réduire de manière significative la pression artérielle systolique et diastolique.
Une lecture de la pression artérielle systolique indique la pression sur les parois artérielles pendant les battements de cœur, tandis qu’une lecture diastolique indique la pression entre les battements de cœur.
Selon les résultats, les Africains semblent bénéficier davantage de la danse-thérapie que ceux d’Europe ou d’Amérique.
Maladie cardiaque chronique
Les personnes souffrant d’insuffisance cardiaque chronique ou en cours ont été comparées à un traitement conventionnel dans une étude plus ancienne de 2014. Il a évalué deux enquêtes impliquant 62 participants à la danse-thérapie, 60 participants à l’exercice et 61 participants témoins.
Une comparaison de la danse-thérapie avec l’exercice et l’absence d’exercice a révélé que la danse-thérapie augmentait la capacité d’exercice et la qualité de vie.
Selon les auteurs, la thérapie par la danse et le mouvement ne différait pas significativement des groupes d’exercices conventionnels en termes de résultats. Par conséquent, elle devrait être incluse dans les programmes de réadaptation cardiaque.
Dance movement therapy is a form of psychotherapy that utilizes dance and movement to improve both mental and physical health. It’s based on the idea that the mind and body are interrelated, so when one is affected, the other will be too. Through this therapy, people can work towards improved wellness by developing strength, coordination, balance, flexibility, self-expression and social skills.
In order to improve one’s overall wellbeing, dance movement therapy can be an expressive form of healing that encourages physical and mental health.
People can use dance movements to express their feelings and emotions to facilitate self-expression, creativity, and connection with their inner selves through sessions with a trained professional.
How does it work?
It seems that dance therapy promotes health by unifying and coordinating all aspects of a person, such as:
In dance, nonverbal communication is as important as verbal communication.
Additionally to serving as a means of communication, movement can also be expressive, functional, or developmental.
Assessment and intervention can both be accomplished through movement.
Possible beneficial effects
Research on the physical, mental, and emotional benefits of dance therapy is inconclusive. Although more studies are necessary, some evidence suggests it may be beneficial in the following areas:
Mental Health
The results of a 2019 meta-analysis that looked at 41 clinical trials and involved 2,374 participants indicated that dance therapy improves:
There is also a possibility that these benefits might be long-term, including anxiety, depression, quality of life, and cognitive skills.
Depression
In contrast to the above meta-analysis, a 2019 review evaluated eight clinical trials that examined dance therapy’s effects on 351 adults struggling with depression.
The authors characterized the evidence as moderate to high quality and concluded that the intervention might offer an effective treatment for adults with depression. As most of the included studies excluded children, teenagers, and older adults, they could not assess its effectiveness for these populations.
Preventing falls
By improving gait, balance, and muscle strength, the authors of a 2017 review examined whether dance, a popular pursuit among older adults, can help prevent falls. As falls are a leading cause of illness and death, the authors reviewed 10 clinical trials that explored the possibility of dance preventing falls. Total participant numbers were 680.
The authors note that dance appears to be safe and demonstrates benefits for well-being among older adults, despite the preliminary nature of their results and the lack of long-term data.
Parkinson’s disease
A 2018 review examined 40 studies and five reviews investigating the effects of dance and music on the symptoms of Parkinson’s disease, which impairs gait, which can increase the risk of falls. The results indicated that the interventions might improve gait.
Care for cancer patients
As well as affecting physical health, cancer often affects emotions and socialization. In order to address these issues, current cancer care increasingly includes psychosocial interventions. A 2015 study examined three clinical trials involving 207 individuals with breast cancer in order to examine the benefits of dance therapy for cancer.
In the data analysis, mixed results were found, but the intervention might help by:
However, it found no evidence that dance therapy can reduce somatization, which is the presentation of multiple physical symptoms caused by psychological factors.
A 2021 review found that dance therapy could improve quality of life for people with breast cancer, but noted that this therapy might be more effective when combined with other therapies.
Blood pressure
In 2020, a meta-analysis of five clinical trials examined the effects of dance therapy on blood pressure. Despite the small number of trials, the results indicated that the intervention could significantly lower systolic and diastolic blood pressure.
A systolic blood pressure reading indicates pressure on the arterial walls during heartbeats, while a diastolic reading indicates pressure between heartbeats.
People from Africa seem to benefit more from dance therapy than those from Europe or America, according to the results.
Chronic heart condition
Individuals with chronic, or ongoing, heart failure were compared with conventional therapy in an older 2014 study. It evaluated two investigations that involved 62 dance therapy participants, 60 exercise participants, and 61 control participants.
A comparison of dance therapy with exercise and no exercise found that dance therapy increased exercise capacity and quality of life. According to the authors, dance therapy did not significantly differ from conventional exercise groups in terms of outcomes. Therefore, dance therapy should be included in cardiac rehabilitation programs.
Atrial fibrillation, also known as AFib, is a common form of abnormal heart rhythm that occurs when the two upper chambers of the heart beat in an irregular fashion.
Around 3.5% of people aged 65-74 years old are affected by this medical condition and it can be lifethreatening if left untreated.
Common treatments for Atrial fibrillation include blood thinners to reduce the risk of stroke and other medications to control arrhythmias.
Atrial fibrillation and stroke
In addition to being diagnosed during a medical examination, atrial fibrillation can also be diagnosed as a result of a stroke, which makes it one of the most common causes of strokes.
A stroke caused by AF is much more serious: one in three people die within 30 days, and one in two within one year. As a result of stagnation of blood in the atria, atrial fibrillation facilitates the formation of clots.
Atrial fibrillation can cause strokes when these clots break off and travel to the brain’s arteries. The risk of stroke is multiplied by five in a patient with atrial fibrillation, depending on other risk factors, such as age, gender, high blood pressure and diabetes.
A number of treatments are available to slow the heart rate and reduce AF, including anticoagulants (antivitamin K or oral anticoagulants). Stroke prevention with aspirin and platelet aggregation inhibitors is rarely prescribed for patients with AF. High blood pressure and other risk factors must be avoided or controlled by people at risk.
The causes of atrial fibrillation
Atrial fibrillation is a condition characterized by an irregular heartbeat caused by chaotic electrical impulses in the atria. It can be caused by high blood pressure, heart attack or valve disorders, thyroid disease, lung disease, diabetes, sleep apnea, alcohol use disorder, and other underlying conditions that can strain or damage the heart’s muscle tissue.
Certain medications or substances can also trigger atrial fibrillation.
Symptoms
The main symptoms are: fatigue, shortness of breath, palpitations with irregular and rapid heartbeats, chest pain, unsteadiness, dizziness, sweating, and nausea. However, some patients are asymptomatic.
The diagnosis
If the patient has rapid, irregular heartbeats, the doctor asks about:
his medical history;
his health problems (does he have heart disease, thyroid problems?);
the frequency of symptoms experienced;
Epidemiology
The number of French people with AF is between 600,000 and 1 million. It is estimated at 350,000 in Canada. The annual incidence is 5/1000 around sixty and 20/1000 after 80 years.
Blood thinners are recommended for people with atrial fibrillation
An updated guide from the American Academy of Neurology recommends that individuals with atrial (or atrial) fibrillation take blood thinners to prevent the risk of stroke.
This particularly concerns those who have already suffered a stroke or a transient brain attack.
The danger of atrial fibrillation (irregular heartbeat) is explained by the fact that the blood stays longer in the atria, which favors the appearance of clots by coagulation phenomenon. The clots can then travel from the heart to the brain. One in 20 people with untreated atrial fibrillation is likely to have a stroke within the next year.
Anticoagulants are medicines that help prevent clots from forming inside the heart and preventing them from traveling to the brain. The newer anticoagulants (dabigatran, rivaroxaban and apixaban) are as (if not more) effective than warfarin, the standard anticoagulant. In addition, the risk of bleeding with warfarin is greater. Source: American Academy of Neurology (AAN).
Atrial fibrillation can accelerate memory problems
Rapid, irregular heartbeats — signs of atrial fibrillation — are quite common in older people, which could trigger early problems with memory and reasoning. “This means that heart health is an important factor related to brain health. says lead study author E. Thacker (University of Alabama at Birmingham, USA).
More than 5000 elderly people, with no history of atrial fibrillation or stroke, were followed for an average of 7 years. At the same time, they took cognitive tests every year. Of the 5,150 participants, 11% developed atrial fibrillation over the 7 years. The study showed that people with atrial fibrillation had lower scores on cognitive tests (memory, reasoning), compared to those without heart problems .
If these results are confirmed, the next steps will have to determine the cause and the means to prevent this cognitive decline, adds Dr. Thacker. Source: American Academy of Neurology (AAN). Rapid, irregular heartbeat may be linked to problems with memory and thinking, 2013.
Il existe de nombreux avantages pour la santé associés à la méditation, autant physiques que mentaux, et c’est une pratique croissante.
Des études soulignent qu’elle peut améliorer le bien-être et la santé mentale en vieillissant, et notamment réduire le risque de maladies neurodégénératives : un atout qui pourrait s’avérer crucial compte tenu de l’espoir croissant de vivre, signe d’une population vieillissante.
La méditation est un excellent moyen de cultiver l’attention mentale et le bien-être émotionnel. Asseyez-vous simplement dans une chaise confortable, respirez profondément par le nez, maintenez-le pendant quelques secondes, puis expirez complètement par le nez. Continuez ce processus de respiration intentionnelle pendant 10 à 15 minutes, en comptant chaque inspiration à haute voix. Gardez votre attention sur le cycle inspiration/expiration, en revenant au comptage chaque fois que votre esprit vagabonde. Il s’agit d’une technique de méditation connue sous le nom de comptage de la respiration.
De nombreux types de méditation, tels que la réduction du stress basée sur la pleine conscience (MBSR), la Méditation Transcendantale® et la pratique du Koan, existent avec peu de preuves que l’un est supérieur à l’autre. La pratique la plus appropriée pour un individu est probablement celle avec laquelle il est le plus facile de rester cohérent.
Des études ont suggéré que la méditation peut améliorer certaines capacités cognitives. Cependant, il n’y a pas suffisamment de données pour déterminer si elle diminue les risques de développer la maladie d’Alzheimer ou si elle profite aux personnes qui en souffrent déjà. Dans l’ensemble, la méditation peut contribuer au bien-être général.
Des bienfaits possibles de la méditation pour les personnes âgées
Il y a des questions précises sur la santé des personnes âgées. Près de 15 % des adultes de plus de 60 ans souffrent de pathologies liées au vieillissement. Le nombre de personnes atteintes de la maladie d’Alzheimer ou d’autres maladies neurodégénératives augmente parallèlement à l’allongement de la durée de vie.
Maintenir la bonne santé mentale de ce public est donc un défi, et toute stratégie de prévention doit être envisagée. Cependant, les effets réels de la méditation n’ont jamais vraiment été étudiés dans cette perspective.
Toute une série de facteurs de risque des maladies neurodégénératives ont été identifiés : tabagisme, pollution, mauvaise alimentation, sédentarité… Il existe plusieurs moyens de les contrer : exercice physique, entraînement cognitif, alimentation saine (de préférence méditerranéenne), éducation à la santé cardiovasculaire… Ces méthodes ont été évaluées dans plusieurs études.
La recherche a cependant largement sous-estimé d’autres facteurs de risque, dont certains sont amplifiés avec l’âge : dépression, stress, anxiété, troubles du sommeil (affectant une personne sur deux de plus de 60 ans), solitude et exclusion de la société. De plus, ces facteurs de risque psychologiques (socio-) émotionnels n’ont pas de programmes d’intervention préventive scientifiquement justifiés.
En ce qui concerne les maladies neurodégénératives chez les personnes âgées, les facteurs de risque psycho-(socio-)affectifs restent peu étudiés. Cependant, la dépression, le stress, l’anxiété, les problèmes de sommeil et la solitude ont un impact réel.
Le projet européen H2020 Silver Health Study vise à combler cette lacune en étudiant les effets de la méditation.
Le projet de recherche européen H2020
Le projet de recherche européen H2020, qui mobilise onze équipes de recherche dans six pays, doit étudier l’impact sur de multiples facteurs associés au vieillissement et à la maladie d’Alzheimer par le biais d’essais cliniques. Trois groupes de 137 participants de plus de 65 ans ont été divisés en trois : un recevant une formation à la méditation (45 personnes), un suivant une activité cognitive (ici, l’apprentissage d’une langue étrangère ; 46 personnes), et le groupe contrôle (pas d’activité spécifique ; 46 personnes) .
Une période d’observation typique dans ce type d’étude est de 2 à 6 mois, et le taux d’attrition (c’est-à-dire le pourcentage de participants quittant l’étude) est d’environ 15 %.
Les résultats sont mitigés
Les régions cérébrales qui devraient être principalement suivies ont été identifiées dans des recherches antérieures.
En plus du cortex cingulaire antérieur, qui intègre des processus affectifs – sentiment émotionnel, rythme cardiaque – avec des processus cognitifs tels que l’anticipation de la récompense, la prise de décision et le contrôle cognitif, l’insula (impliquée dans les émotions, l’intéroception, la dépendance, la conscience…) a également joué un rôle.
L’étude d’interventions établies sur le mode de vie telles que la méditation pose un défi lorsqu’il s’agit de définir un groupe placebo approprié. Par exemple, dans de nombreux essais de méditation, le groupe témoin inclut soit l’écoute d’une musique apaisante, soit des personnes inscrites sur une liste d’attente. D’autre part, les essais cliniques sur les médicaments impliquent généralement qu’une moitié des participants reçoivent le médicament et l’autre moitié un placebo, une réplique exacte qui ne contient aucun médicament actif (appelée pilule de sucre). Il est important d’avoir de bons groupes placebo car avoir des attentes concernant l’obtention d’un traitement peut souvent créer une amélioration de l’état. Même certains contrôles placebo, y compris la musique, peuvent avoir des effets positifs.
Il n’est pas certain que la méditation ait un impact direct sur la diminution du risque de maladie d’Alzheimer. Cependant, il existe d’autres conditions qui peuvent être aidées par son utilisation. Les niveaux de stress et d’anxiété peuvent être réduits et le sommeil amélioré, comme le risque cardiovasculaire et la tension artérielle. En prime, il est économique et sans stress à mettre en œuvre dans son style de vie. Il existe de nombreuses ressources en ligne, dans des livres et des cours qui peuvent aider à apprendre différentes techniques. Et, si s’éloigner de la technologie aide, il existe de nombreuses applications téléphoniques proposant un soutien à la méditation.
There are many health benefits associated with meditation, both physical and mental, and it is a growing practice. Studies are pointing out that it may improve well-being and mental health in aging, and particularly reduce the risk of neurodegenerative disease: an asset that could prove crucial given the increasing hope of life, which is a sign of an aging population.
Meditation is a great way to cultivate mental attention and emotional wellbeing. Simply sit in a comfortable chair, take a deep breath through the nose, hold it for a few seconds, and then exhale fully through the nose. Continue this process of intentional breathing for 10-15 minutes, counting each inhalation aloud. Keep your awareness on the inhaling/exhaling cycle, returning to the counting whenever your mind wanders. This is one technique of meditation known as breath counting.
Many kinds of meditation, such as mindfulness-based stress reduction (MBSR), Transcendental Meditation®, and Koan practice, exist with little proof that one is superior to another. The most suitable practice for an individual is probably the easiest one for them to stay consistent with. Studies have suggested meditation can improve some cognitive abilities, yet there is insufficient data to determine if it diminishes the chances of Alzheimer’s or benefits individuals already suffering from it. All in all, meditation may contribute towards overall well-being.
The possible benefits of meditation for the elderly
There are specific questions about the health of seniors. Almost 15% of adults over 60 suffer from pathologies associated with aging. The number of people affected by Alzheimer’s disease or other neurodegenerative diseases is increasing along with the increase in lifespan.
Keeping the good mental health of this public is therefore a challenge, and any preventative strategy should be considered. However, meditation’s real effects have never really been studied from this perspective.
In this paper, we present the results, and perspectives of a study conducted as part of the Age-Well project (Silver Health Study program).
A whole series of risk factors for neurodegenerative diseases have been identified: smoking, pollution, poor diet, physical inactivity, etc. There are several methods to counter them: exercise, cognitive training, a healthy diet (preferably Mediterranean), cardiovascular health education… These methods have been evaluated in several studies.
The research, however, has largely underestimated other risk factors, some of which are amplified with age: depression, stress, anxiety, sleep problems (affecting one out of two people over 60), loneliness, and exclusion from society. Furthermore, these psychological-(socio-)emotional risk factors do not have scientifically substantiated preventive intervention programs.
In terms of neurodegenerative diseases among the elderly, psycho-(socio-)affective risk factors remain understudied. However, depression, stress, anxiety, sleep problems, and loneliness have a real impact.
The European project H2020 Silver Health Study aims to fill this deficiency by studying the effects of meditation.
The European research project H2020
The European research project H2020, which involves eleven research teams in six countries, is to study the impact on multiple factors associated with aging and Alzheimer’s disease through clinical trials.
Three groups of 137 participants over 65 were divided into three: one receiving meditation training (45 people), one following a cognitive activity (here, learning a foreign language; 46 people), and the control group (no specific activity; 46 people).
A typical observation period in this type of study is 2 to 6 months, and the attrition rate (i.e. the percentage of participants leaving the study) is about 15%.
Results are mixed
Brain regions that should be tracked primarily have been identified in previous research.
As well as the anterior cingulate cortex, which integrates affective processes – emotional feeling, heartbeat – with cognitive processes such as reward anticipation, decision-making, and cognitive control, the insula (involved in emotions, interoception, dependence, consciousness…) also played a role.
Studying interventions based on lifestyle such as meditation poses a challenge when it comes to defining an appropriate placebo group. For example, in many meditation trials the control group involves either calming music or people put on a waiting list. On the other hand, drug clinical trials commonly involve one half of the participants receiving the medication and another half being given a placebo—an exact replica which does not contain any active drugs (known as a sugar pill). It is important to have good placebo groups since having expectations about getting a treatment can often create an improvement in condition. Even certain placebo controls including music may have positive effects.
It is not definitive whether meditation has a direct impact on decreasing the chance of Alzheimer’s disease. However, there are other conditions that can be helped through its use. Stress and anxiety levels may be reduced and sleep improved, as can cardiovascular risk and blood pressure. As an added bonus, it is economical and stress-free to implement into one’s lifestyle. There are many resources online, in books and classes that may help with learning different techniques. And if getting away from technology helps, there are plenty of phone apps offering support with meditation.
